Related Experiment Video
Updated: Feb 6, 2026

04:17
Author Spotlight: Decoding Corneal Neovascularization with Alkali Burn Model for Future Therapeutic Strategies
Published on: June 30, 2023
4.2K
Corneal angiogenesis and lymphangiogenesis
Birgit Regenfuss1, Felix Bock, Claus Cursiefen
1Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany.
Current Opinion in Allergy and Clinical Immunology
|September 7, 2012
Summary
Corneal lymphangiogenesis varies between mouse strains and can occur independently of blood vessel growth. Understanding these differences can improve targeted therapies for blood and lymphatic vessel growth.
Area of Science:
- Ophthalmology
- Vascular Biology
- Genetics
Background:
- Corneal lymphangiogenesis, the growth of lymphatic vessels in the cornea, is a significant factor in ocular disease.
- Understanding the interplay between blood and lymphatic vessel growth is crucial for developing effective treatments.
Purpose of the Study:
- To review novel antilymphangiogenic treatments.
- To discuss recent findings on how mouse strain affects corneal lymphangiogenesis.
- To explore the relationship between blood and lymphatic vessel growth.
Main Methods:
- Review of existing literature on corneal lymphangiogenesis.
- Analysis of studies investigating strain-dependency in mice.
- Examination of research on the interdependency of vascular networks.
Main Results:
- Lymphangiogenesis in mice exhibits significant strain-dependent variations.
- Both normal and inflammatory conditions influence these variations.
- Blood and lymphatic vessel growth, while interconnected, can also occur independently.
Conclusions:
- Genetic factors influence lymphangiogenesis, impacting treatment strategies.
- Further understanding of coordinated vascular growth is key to developing targeted anti-angiogenic therapies.
- Developing specific anti-haemangiogenic or antilymphangiogenic strategies requires detailed knowledge of these processes.
Related Concept Videos
Mechanism of Angiogenesis
6.9K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.9K
Regulation of Angiogenesis and Blood Supply
3.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.5K

